Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
about
Immunohistochemical markers informing the diagnosis of sebaceous carcinoma and its distinction from its mimics: Adipophilin and factor XIIIa to the rescue?Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.The Actionability of Exome sequencing testing results.Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma.MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature.
P2860
Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@en
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@nl
type
label
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@en
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@nl
prefLabel
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@en
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@nl
P2093
P2860
P356
P1476
Next-generation sequencing ide ...... genes in sebaceous carcinoma.
@en
P2093
Bita Esmaeli
Bogdan A Czerniak
Courtney W Hudgens
Daniel A Wimmer
Diana Bell
Elena G Seviour
Jonathan L Curry
Michael A Davies
P2860
P356
10.1002/PATH.4759
P577
2016-06-11T00:00:00Z